Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEAT: H. pylori Eradication in Aspirin Users
NCT01506986Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Mar 2012
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lansoprazole, clarithromycin and metronidazole in Helicobacter pylori infection (2 arms), sponsored by University of Nottingham. Primary endpoint: Rate of hospitalisation due to peptic ulcer bleeding at 4 years. Started Mar 2012; status: completed.
02
Drugs
lansoprazoleclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01506986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506986.